GlaxoSmithKline PLC | Cash Flow
Fiscal year is January-December. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,628
2,831
8,372
1,062
2,169
4,046
Depreciation, Depletion & Amortization
1,414
1,484
1,630
1,774
1,922
1,856
Other Funds
302
897
4
955
686
43
Funds from Operations
6,329
3,876
236
4,148
5,129
5,531
Changes in Working Capital
221
661
1,675
1,727
1,078
2,235
Net Operating Cash Flow
6,550
4,537
1,911
5,875
6,207
7,766
Capital Expenditures
1,701
1,751
1,901
2,352
2,202
Sale of Fixed Assets & Businesses
1,897
264
10,318
187
584
Purchase/Sale of Investments
362
115
821
576
169
Net Investing Cash Flow
141
1,146
5,933
1,379
1,521
Cash Dividends Paid - Total
3,680
3,843
3,874
4,850
3,906
Issuance/Reduction of Debt, Net
10
228
2,403
78
990
Net Financing Cash Flow
4,936
4,678
6,307
5,712
5,591
Net Change in Cash
1,325
1,203
1,492
933
1,005
Free Cash Flow
5,362
3,349
531
4,332
4,662
Deferred Taxes & Investment Tax Credit
-
-
-
-
263
414
Net Assets from Acquisitions
835
104
3,541
-
120
Other Sources
136
330
236
283
48
Change in Capital Stock
964
166
26
15
9
Exchange Rate Effect
148
84
45
283
100
About GlaxoSmithKline
View Profile
